Evdokia Anagnostou is a child neurologist and senior scientist at Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada. She is also professor of pediatrics at the University of Toronto.
Evdokia Anagnostou
Senior scientist
Holland Bloorview Kids Rehabilitation Hospital
From this contributor
Social perception problems cut across disorders
The ability to recognize emotions varies along a continuum that spans autism, attention deficit hyperactivity disorder and obsessive-compulsive disorder.
Social perception problems cut across disorders
Frontline diagnosis of autism
Targeted training opportunities and comprehensive guidelines can help community physicians diagnose many cases of autism, say Evdokia Anagnostou and Jessica Brian.
Frontline diagnosis of autism
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.